TY - JOUR
T1 - Renal denervation causes chronic hypotension in rats
T2 - Role of β1-adrenoceptor activity
AU - Jacob, Frédéric
AU - LaBine, Brian G.
AU - Ariza, Pilar
AU - Katz, Stephen A.
AU - Osborn, John W.
PY - 2005/4
Y1 - 2005/4
N2 - 1. Renal denervation (RDNX) chronically lowers mean arterial pressure (MAP) in normal rats but mechanisms leading to this hypotensive response remain unknown. 2. We hypothesized that this sustained decrease in arterial pressure was because of a loss of β1-adrenoceptor mediated renin secretion. Male Sprague-Dawley rats were assigned to sham (SHAM; n = 9), unilateral (UniRDNX; n = 9), or bilateral (RDNX; n = 10) renal denervation groups and instrumented for telemetric MAP measurements, plasma renin concentration (PRC) measurements and intravenous infusion. Twenty-four h MAP, heart rate, sodium and water balances were recorded 5 days before, 3 days during and 3 days after 1-adrenoceptor blockade with atenolol. 3. The 5-day control MAP was significantly lower in RDNX (97 ± 1 mmHg) compared to SHAM (105 ± 2 mmHg) and UniRDNX (102 ± 2 mmHg) rats. No significant differences in basal PRC were observed between RDNX (2.2 ± 0.3 ngAng1/mL per h), UniRDNX (2.6 ± 0.4 ng/Ang1/mL per h) and SHAM (2.6 ± 0.4 ngAng1/mL per h) rats. By day 1 of atenolol, PRC was significantly lower in UniRDNX rats (1.8 ± 0.2 ngAg1/mL per h) compared to control values, but was unchanged during atenolol infusion in the other groups. By day 3 of atenolol, MAP was significantly decreased in all groups, but the absolute levels of MAP remained statistically different between RDNX (87 ± 1 mmHg) and SHAM (91 ± 1 mmHg) groups. 4. We conclude that the arterial pressure lowering effect of RDNX is not solely dependent on the loss of neural control of renin release.
AB - 1. Renal denervation (RDNX) chronically lowers mean arterial pressure (MAP) in normal rats but mechanisms leading to this hypotensive response remain unknown. 2. We hypothesized that this sustained decrease in arterial pressure was because of a loss of β1-adrenoceptor mediated renin secretion. Male Sprague-Dawley rats were assigned to sham (SHAM; n = 9), unilateral (UniRDNX; n = 9), or bilateral (RDNX; n = 10) renal denervation groups and instrumented for telemetric MAP measurements, plasma renin concentration (PRC) measurements and intravenous infusion. Twenty-four h MAP, heart rate, sodium and water balances were recorded 5 days before, 3 days during and 3 days after 1-adrenoceptor blockade with atenolol. 3. The 5-day control MAP was significantly lower in RDNX (97 ± 1 mmHg) compared to SHAM (105 ± 2 mmHg) and UniRDNX (102 ± 2 mmHg) rats. No significant differences in basal PRC were observed between RDNX (2.2 ± 0.3 ngAng1/mL per h), UniRDNX (2.6 ± 0.4 ng/Ang1/mL per h) and SHAM (2.6 ± 0.4 ngAng1/mL per h) rats. By day 1 of atenolol, PRC was significantly lower in UniRDNX rats (1.8 ± 0.2 ngAg1/mL per h) compared to control values, but was unchanged during atenolol infusion in the other groups. By day 3 of atenolol, MAP was significantly decreased in all groups, but the absolute levels of MAP remained statistically different between RDNX (87 ± 1 mmHg) and SHAM (91 ± 1 mmHg) groups. 4. We conclude that the arterial pressure lowering effect of RDNX is not solely dependent on the loss of neural control of renin release.
KW - Arterial pressure
KW - Plasma renin concentration
KW - Renal denervation
KW - Sprague-Dawley rats
KW - β-adrenergic blockade
UR - http://www.scopus.com/inward/record.url?scp=17844407632&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=17844407632&partnerID=8YFLogxK
U2 - 10.1111/j.1440-1681.2005.04179.x
DO - 10.1111/j.1440-1681.2005.04179.x
M3 - Article
C2 - 15810988
AN - SCOPUS:17844407632
SN - 0305-1870
VL - 32
SP - 255
EP - 262
JO - Clinical and Experimental Pharmacology and Physiology
JF - Clinical and Experimental Pharmacology and Physiology
IS - 4
ER -